IN.PACT™ Admiral™ drug‐coated balloon: Durable, consistent and safe treatment for femoropopliteal peripheral artery disease☆ | Semantic Scholar
Frontiers | The factors influencing the efficiency of drug-coated balloons
Medtronic's In.Pact 018 Drug-Coated Balloon Receives FDA Approval for PAD - Endovascular Today
Drug-coated balloon therapy in coronary and peripheral artery disease | Nature Reviews Cardiology
Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial - The Lancet
Drug-Coated Balloons Expand Treatment Options
The Drug-Coated Balloon: Not Just a Balloon
Drug-Coated Balloon for Small Coronary Artery Disease in Patients With and Without High-Bleeding Risk in the BASKET-SMALL 2 Trial | Circulation: Cardiovascular Interventions
Comparative Analysis of Drug-Coated Balloons - Endovascular Today
US FDA approves first drug-coated balloon for treatment of in-stent restenosis - Vascular News
What are the Pathological Concerns and Limitations of Current Drug-coated Balloon Technology? – touchCARDIO
Clinical Application of Drug-Coated Balloon in The Treatment of Coronary Artery Disease - Kossel Medtech
Current status, challenges and future directions of drug-eluting balloons | Future Cardiology